Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Recommendation of "Buy" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Leerink Partnrs Weighs in on Zentalis Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:ZNTL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […]